Laura Holman to Survival Rate
                            
                            
                                This is a "connection" page, showing publications Laura Holman has written about Survival Rate.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.082
         
        
        
     
 
    
        
        - 
            Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial. Ann Oncol. 2024 Nov; 35(11):981-992.
            
            
                Score: 0.052
            
         
        
        - 
            Primary and acquired platinum-resistance among women with high grade serous ovarian cancer. Gynecol Oncol. 2016 08; 142(2):225-30.
            
            
                Score: 0.029